What is more striking is that additional pathogenic variants in the LMNA gene (such as the p.R482Q variant associated with FPLD2) were also found in patients with metabolic abnormalities in the lipodystrophy spectrum, but without a clinical diagnosis [12]. The gene discussed is LMNA; the disease is lipodystrophy.